Rachel A. McConnell, MD, F.A.C.O.G., F.A.C.S.

Full Curriculum Vitae

Biosketch

Born in Shreveport, Louisiana, Dr. Rachel McConnell graduated from Southern University in Shreveport receiving an A.S. degree in Physics. She continued her education at Southern University in Baton Rouge where she graduated magna cum laude receiving a B.S. degree in Chemistry. She then launched her medical career attending Louisiana State University Medical School in Shreveport where she received her M.D. in 1986. Her postgraduate training includes, Internship and residency training at Tulane University Medical Center in New Orleans and in 1992 she successfully completed a Clinical Research Fellowship in Reproductive Endocrinology and Infertility with the Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology at the University of Southern California School of Medicine in Los Angeles.

Dr. McConnell was appointed as Assistant Professor and Chief of the Division of Reproductive Endocrinology and Infertility in the Department of Obstetrics and Gynecology at the University of Nevada School of Medicine in Las Vegas in July 1992. Dr. McConnell was instrumental in the successful development of the University Institute for Fertility, of which she was the Medical Director.

Since leaving University of Nevada School of Medicine and going into private practice Dr. McConnell maintains her association in the capacity of Assistant Professor and Clinical Faculty with the School of Medicine. Her clinical interests are Polycystic ovary syndrome, Oocyte donation, Treating Unwanted Facial Hair, and Stress in IVF patients. Dr. McConnell's special research interest is the mechanism of embryo implantation.

Dr. McConnell is a fellow member of the American College of Obstetricians and Gynecologists, fellow of the American College of Surgeons and an associate member of the American Society for Reproductive Medicine. Dr. McConnell is board certified in OB/Gyn and Reproductive Endocrinology and Infertility. She is also active in the Clark County Medical Society, and the Nevada State Medical Association and their affiliated obstetrics and gynecology chapters.

Curriculum Vitae

Certifications:

• Board certified by the American Board of Obstetrics and Gynecology 1990, 1993
• Board Certified by The Board of Reproductive Endocrinology and Infertility, March 1999

Licensures:

• State of Nevada
• State of California
• State of Louisiana

Medical School:

1982-1986 Louisiana State University,School of Medicine,Shreveport, Louisiana(M.D.)

Postgraduate Training:

Internship:
1986-1987 Department of Obstetrics and Gynecology, Tulane University Medical Center, New Orleans, Louisiana

Residency:
1987-1990 Department of Obstetrics and Gynecology, Tulane University Medical Center, New Orleans, Louisiana

Fellowship:
1990-1992 Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Southern California (USC), School of Medicine, Los Angeles, California

Society Memberships:

• American College of Obstetricians and Gynecologists, Junior Member
• American Fertility Society, Associate Member
• American Medical Association
• American College of Surgeons
• Society of Reproductive Endocrinologists
• Pacific Coast Fertility Society
• Clark County Medical Society
• Nevada State Medical Association
• North American Menopause Society
• American Diabetes Association

Honors:

• Chief Administrative Resident
• Outstanding Residency Performance Award
• Owl Club Best Resident Teacher
• Magma Cum Laude Graduate
• Undergraduate Research Award
• Alpha Chi Honor Society
• Alpha Kappa Mu Honor Society

Research Experience:

Chemical Analyst
Boots Pharmaceutical Company
Shreveport, Louisiana
(1981-1982)

Research Assistant
Quantitative Analysis Laboratory
Baton Rouge, Louisiana
(1979-1981)

Publications

Peer Review Journals:

• Smith LG Jr., Summers PR, Miles RW, Biswas MK, Pernoll ML: Gonococcal chorioamnionitis associated with sepsis: A case report. Am J Obstet Gynecol 1989; 160:573-4
• Witt BR, Miles RA, Thorneycroft IH: CA-125 levels in abruptio placenta. Am J Obstet Gynecol 1991; 164:1225-8.
• Carmina E, Stanczyk FZ, Chang L, Miles RA, Lobo RA: The ratio of adrostenedione/11a hydroxyandrostenedione is an important marker of adrenal androgen excess in women. Fertil Steril 1992; 58 (1): 148-52.
• Miles RA, Cassidenti DL, Carmina E, Getzschein R, Stanczyk FZ, Lobo RA; The cutaneous application of an Androstenedione gel as an in vivo test of 5a - reductase activity in women. Fertil Steril; 1992 (4): 708-12.
• Miles RA, Lobo RA, Getzchein E, Moyer D, Press MF, Koopersmith T, Paulson RJ, Sauer, MV: Assessing the pharmacodynamic properties of exogernously administered progesterone: A comparison of micronized vaginal delivery to intramuscular routes. Fertil Steril 1994.

Abstracts

• Witt BR, Miles RA, Wolf GC, Koulianos GT, Thorneycroft IH. Serum CA-125 levels in placental abruption. Presented at the 46th Annual Meeting of the American Fertility Society, October 15-18, 1990, Washington, D.C.
• Miles RA, Cassidenti DL, Carmina E, Gentzschein E, Stanczyk FS, Lobo RA: Percutaneous Androstenedione as an in vivo test of inherent 5 –reductase activity (5a-RA). Presented at the 38th Annual Meeting of the Society for Gynecologic Investigation, March 20-23, 1991, San Antonio, Texas.
• Carmina E, Stanczyk FZ, Chang L, Miles RA, Lobo RA: The ratio of adrostenedione (A)/11a-hydrosyandrostenedione (11a-A) is an important marker of adrenal androgen excess in women. Presented at the 39th Annual Meeting of the Pacific Coast Fertility Society, April 10-14, 1991, Indian Well, California.
• Miles RA, Lobo RA, Paulson RJ, Sauer MV: The use of testolactone to prevent ovarian hyperstimulation syndrome (OHSS) after gonadotropin therapy. Submitted for possible presentation at the 39th Annual Meeting of the Society for Gynecologic Investigation, March 18-21, 1992, San Antonio, Texas.
• Cassidenti DL, Miles RA, Vijod A, Press M, Paulson RJ, Sauer MV: Comparing responses to varying hormone replacement regimens prior to embryo donation. Submitted for possible presentation at the 39th Annual Meeting of the Society for Gynecologic Investigation, March 18-21, 1992, San Antonio, Texas.
• Miles RA, Lobo RA, Getzchein E, Moyer D, Press MF, Koopersmith T, Paulson RJ, Sauer MV: Assessing the pharmacodynamic properties of exogernously administered progesterone: A comparison of micronized vaginal delivery to intramuscular routes. Presented at the 40th Annual Meeting of the Pacific Coast Fertility Society, April 8-12, 1992, Indian Well, California.
• Miles RA, Getzchein E, Goedert L, Stanczyk FZ, Lobo RA: Assessment of androgen suppression using Androstenedione gel. Presented at the 40th Annual Meeting of the Pacific Coast Fertility Society, April 8-12, 1992, Indian Wells, California.

 

Last updated: November 25, 2006
Reviewed by Dr. Rachel McConnell and her medical staff